Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-24 @ 5:48 PM
NCT ID:
NCT01279668
Eligibility Criteria:
Inclusion Criteria:
* Male or Female, aged 16 years to 49 years inclusive.
* Presenting with a persistent cough of 2-8 weeks' duration without an established diagnosis (e.g. asthma, gastro-oesophageal reflux).
* Able to complete cough diary and study questionnaires.
Exclusion Criteria:
* There is a contraindication to montelukast.
* Chronic severe disease which may cause persistent cough (eg cystic fibrosis, bronchiectasis, cardiac failure).
* Immunodeficiency/immunocompromised state.
* Pregnancy.
* Breastfeeding.
* Current smoker (i.e. stopped smoking less than 6 months ago).
* Regular medication associated with persistent cough (ACE inhibitors).
* The individual is in another clinical research study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
49 Years
Study:
NCT01279668
Study Brief:
Protocol Section:
NCT01279668